Market is mostly right, and even if it’s wrong (undervalued) it does not remain wrong for too long, The way everything is going with Lumos , I am assuming FebriDx is a commercially failed product and it’s clearly reflected on LDX price action.
If there was even an hint of it getting successful on market , say in one year time ,its price wouldn’t be sitting at where it is now. Also there are many red flags *management not buying , no new distribution/sales news etc
I researched good amount and believed in FebriDx and invested heavily on it and have suffered substantial losses. I still wish FebriDx would be a success but I don’t see it happening.
Market is mostly right, and even if it’s wrong (undervalued) it...
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
-0.004(8.70%) |
Mkt cap ! $20.21M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.2¢ | $230.1K | 5.259M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 534989 | 4.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 221428 | 2 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| LDX (ASX) Chart |